Locations
Copenhagen, Denmark · Søborg, Denmark
industry
Biotechnology
Size
11-50 employees
Stage
Seed
founded in
2013
Fida Biosystems (FIDABIO) offers a new proprietary technology developed for quantification and characterization of proteins and nanoparticles from 0.5 to 1,000 nm DH, including antibodies, liposomes, exosomes, membrane embedded proteins, et al. Based on accurate, in-solution, absolute measurements of hydrodynamic radius, the technology provides precise information about KD, concentration, size, stoichiometry, conformational changes, oligomeric state, immunogenicity, multiple bindings, etc. It is characterized by being fast (minutes), requiring very small sample amounts (µL-nL), and being exceptionally tolerant to the sample matrix, including plasma, serum, cell lysate, fermentation media, etc. Contrary to most other procedures, the methodology is based on binding in homogeneous solution; complications related to non-specific surface adsorption and challenging assay development are therefore avoided.
Something looks off?